🔗 Permalink

Inventor profile of:

David E. Anderson

City:

Boston, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2018-10-11

Top Assignees for applications by David E. Anderson

The entities that hold a legal rights for patent applications filed by inventor Anderson David E.:

VARIATION BIOTECHNOLOGIES INC. 10 Ottawa, Canada
VARIATION BIOTECHNOLOGIES, INC. 6 Gatineau, QC Canada
VARIATION BIOTECHNOLOGIES, INC. 3 Gatineau, Canada
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 2 Boston, MA United States
Variation Biotechnologies Inc. 2 Ontario, Canada
SORBONNE UNIVERSITE 1 Paris, France
Variation Biotechnolgies, Inc. 1 Gatineau, Canada
Variation Biotechnologies, Inc. 1 Gatineu, Canada

Recent patent applications by Anderson David E.

David E. Anderson from Boston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-10-11

US20180289794A1

Human necessities

Vaccine compositions for treatment of Zika virus

#2 | 2018-09-27

US20180274044A1

Chemistry; metallurgy

Methods for detection of anti-cytomegalovirus neutralizing antibodies

#3 | 2018-09-13

US20180256723A1

Human necessities

Compositions and methods for treating viral infections

#4 | 2018-08-16

US20180228899A1

Human necessities

Methods and compositions for therapeutic agents

#5 | 2017-12-07

US20170349634A1

Chemistry; metallurgy

Compositions and methods for treatment of cytomegalovirus

#6 | 2017-12-05

US15642950

Human necessities

Vaccine compositions for treatment of Zika virus

#7 | 2017-06-08

US20170159016A9

Chemistry; metallurgy

Selective differentiation, identification, and modulation of human TH17 cells

#8 | 2015-10-15

US20150290306A1

Human necessities

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF MALIGNANT GLIOMAS

#9 | 2015-03-19

US20150079077A1

Human necessities

METHODS AND COMPOSITIONS FOR THERAPEUTIC AGENTS

#10 | 2015-02-19

US20150050732A1

Chemistry; metallurgy

SELECTIVE DIFFERENTIATION, IDENTIFICATION, AND MODULATION OF HUMAN TH17 CELLS

#11 | 2015-02-12

US20150044668A1

Chemistry; metallurgy

Methods for detection of anti-cytomegalovirus neutralizing antibodies

#12 | 2014-12-18

US20140370041A1

Human necessities

Compositions and methods for treating influenza

#13 | 2014-12-04

US20140356399A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS

#14 | 2014-10-16

US20140308308A1

Chemistry; metallurgy

Compositions and methods for treatment of cytomegalovirus

#15 | 2013-12-05

US20130323280A1

Human necessities

METHODS FOR PREPARING VESICLES AND FORMULATIONS PRODUCED THEREFROM

#16 | 2013-11-07

US20130295165A1

Human necessities

Compositions and methods for treating viral infections

#17 | 2013-05-02

US20130108692A1

Human necessities

Compositions and methods for treating influenza

#18 | 2012-07-12

US20120177683A1

Human necessities

Methods for preparing vesicles and formulations produced therefrom

#19 | 2012-06-21

US20120156240A1

Human necessities

Methods for preparing vesicles and formulations produced therefrom

#20 | 2011-07-21

US20110177163A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS A

#21 | 2011-04-28

US20110097418A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING INFLUENZA

InventorID:

222133 ⎘